---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-002537"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T09:27:34.150172+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stryker to acquire Inari Medical for $80/share cash, ~$4.9B equity value

## Summary
- Stryker will pay $80 per share in cash for all outstanding Inari shares; total fully diluted equity value ~$4.9B.
- Transaction expands Stryker into peripheral vascular segment, adding VTE thrombectomy solutions.
- Boards of both companies unanimously approved; transaction expected to close by end of Q1 2025.
- Tender offer requires majority share minimum tender, HSR waiting period expiration, and other customary conditions.
- Inari (NARI) shareholders will receive $80/share; remaining shares acquired via second-step merger at same price.

## SEC filing metadata
- accession: 0001193125-25-002537
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/0001193125-25-002537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/d899660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-002537
- JSON: https://secwatch.observer/filing/0001193125-25-002537.json
- Plain text: https://secwatch.observer/filing/0001193125-25-002537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.